Latest news

Zachary Karl, Vice President Business Development @ Bio Innovations Midwest 2025

World Bio Markets: AI - A tool U.S. industrial biomanufacturing cannot ignore

Inside Biotech podcast interviews CEO, Michael Heltzen

Podcast: 'Inside Biotech' interviews CEO, Michael Heltzen

CCO Damien Perriman and co-founder and VP of Development, Dr. Paul Opgenorth.

Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical Committees

MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health Epidemic

The challenges of SynBio

Transcript: Q2 2025 Earnings Call

eXoZymes provides second quarter 2025 update at 5PM EST today

eXoZymes to host second quarter 2025 update on Tuesday August 12, 2025, at 5PM EST

eXoZymes details biomanufacturing breakthrough: 4 grams of NCT with over 99% purity

eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 months